doi: 10.1001/archneur.1992.00530350051019
10.1152/ajpendo.00005.2017 Summary Keywords glucagon-like peptide-1, metabolic disease, type 2 diabetes, enteroendocrine cell system, GPCR, L-cells, microbiome, -cells Citation Paternoster S and Falasca M (2018) Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
from France examined the influence of commercially available collagen peptide supplementation on skin and nail health in an aging East Asian population via a double-blind, randomized, placebo-controlled trial [52]
Results Characteristics of participants We recruited 24 individuals with obesity into this study (Table 1)
Ethics The study protocol was approved by an independent ethics committee (Comitato Etico Cantonale, Canton Ticino, Switzerland)